Veterinary Medicines

REMACYCLINE L.A., soluție injectabilă

Not authorised
  • Oxytetracycline
Download as PDF

Product identification

Medicine name:
REMACYCLINE L.A., soluție injectabilă
Active substance:
  • Oxytetracycline
Target species:
  • Pig
  • Sheep
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Oxytetracycline
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        21
        day
    • Sheep
      • Meat and offal
        21
        day
      • Milk
        7
        day
    • Cattle
      • Meat and offal
        21
        day
      • Milk
        7
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01AA06
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Surrendered
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dopharma Research B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dopharma France S.A.S.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 190240
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 31/07/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."